Aurora Biosynthetics is a state-of-the-art RNA manufacturing partner providing comprehensive, end-to-end solutions for the production of critical drug components, including plasmid DNA, mRNA, and lipid nanoparticles (LNPs). Located in Sydney, Australia, Aurora integrates process and analytical development, GMP manufacturing, and fill/finish services under one roof. This streamlined approach significantly reduces manufacturing risks and accelerates timelines, enabling biotechnology and pharmaceutical companies worldwide to rapidly advance their innovative RNA-based therapies.
Leveraging strategic public-private partnerships and deep industry expertise, Aurora is uniquely positioned to address the growing global demand for reliable, high-quality RNA manufacturing solutions.
Company Details
- Address
- The Growing Global Demand For Reliable
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://aurorabiosynthetics.com/
Aurora Biosynthetics Questions
Aurora Biosynthetics's website is https://aurorabiosynthetics.com/
Aurora Biosynthetics's LinkedIn profile is https://www.linkedin.com/company/aurora-biosynthetics
Aurora Biosynthetics's industry is
Biotechnology Research
Aurora Biosynthetics's top competitors are
Mvmnt-X, Inc.,
Jomar Life Research,
Enhanced Analgesics,
Abbvie,
Facio Biotherapies Pty Ltd,
Prescient Therapeutics,
The Venture Network,
Myeloid Therapeutics,
Biointelect Pty Ltd,
Pronswer Group.
Aurora Biosynthetics's categories are Biotechnology Research
